GlassScriptPhysician profile
Craig H Harcup
NPI 1497781793
$7,873.03
in general payments reported to CMS, 2019-2025
38 companies · $2,634 in 2025
The $2,634 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $126 · 2021: $633 · 2022: $930 · 2023: $1,230 · 2024: $2,076 · 2025: $2,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,905 · Education: $34.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,905.42 |
| Education | $34.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,262.09 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $1,077.99 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $919.93 | 2019-2025 | Ofev, Jascayd |
| United Therapeutics Corporation | $789.70 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Grifols USA, LLC | $536.26 | 2021-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $490.15 | 2022-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $363.82 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Genzyme Corporation | $329.54 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $310.12 | 2023-2025 | Winrevair, Zerbaxa, Recarbrio |
| Actelion Pharmaceuticals US, INC. | $227.37 | 2019-2025 | Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $210.00 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $198.57 | 2021-2025 | Glassia |
| Shionogi INC | $130.83 | 2023-2024 | Fetroja |
| Verona Pharma, INC. | $97.85 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $97.59 | 2020-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $81.77 | 2021-2023 | |
| Electromed, INC. | $71.08 | 2022-2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $69.85 | 2022-2023 | Nuzyra |
| Inogen, INC. | $67.29 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $60.67 | 2019-2022 | |
| Harmony Biosciences LLC | $57.97 | 2021-2024 | |
| Covis Pharma Gmbh | $57.23 | 2022 | |
| Nabriva Therapeutics, Plc | $39.23 | 2021-2022 | |
| Pulmonx Corporation | $35.27 | 2022 | |
| Genentech USA, INC. | $34.83 | 2022 | |
| Jazz Pharmaceuticals INC. | $29.28 | 2021 | |
| Amgen INC. | $28.59 | 2025 | Tavneos |
| Inspire Medical Systems, INC. | $26.79 | 2023 | Inspire |
| Lilly USA, LLC | $21.90 | 2025 | Zepbound |
| Vapotherm INC | $21.90 | 2022 | |
| Pharming Healthcare, INC. | $20.18 | 2023 | Ruconest |
| Boston Scientific Corporation | $18.22 | 2019 | |
| Csl Behring | $16.22 | 2021 | |
| Baxter Healthcare | $15.75 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Tactile Systems Technology INC | $15.53 | 2024 | Entre Plus, Flexitouch Plus |
| Teva Pharmaceuticals USA, INC. | $14.82 | 2021 | |
| Advanced Respiratory, INC | $14.00 | 2021 | |
| Itamar Medical INC | $12.85 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Harcup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.